Source Count: 15 | Weighted Score: 31 | Source Confidence: [4/5] | Primary Tier: 1 | Last Updated: March 11, 2026
Keywords: altitude sickness, hypoxia, third-man factor, Everest, high-altitude cerebral edema, HACE, mountain psychology, hallucinations, acclimatization, mountaineering
Category Tags: altered-states, physiology, mountains, hypoxia, survival
Cross-References: Y_2_01 — Hypoxia and Consciousness · O_5_11 — Mountain Anomalies · R_2_14 — Respiratory Physiology

QUICK SUMMARY

Altitude sickness — a spectrum of syndromes caused by hypobaric hypoxia (reduced oxygen partial pressure at elevation) — produces some of the most dramatic and well-documented involuntary altered states of consciousness experienced in natural environments. Above approximately 2,500 meters (8,200 feet), the reduced partial pressure of oxygen begins to produce measurable cognitive and physiological effects; at extreme altitude (>7,000 meters / 23,000 feet — the so-called "death zone"), severe hypoxia produces hallucinations, disorientation, impaired judgment, and dissociative experiences that have been reported by virtually every climber who has operated at those heights without supplemental oxygen. The most famous altitude-related altered state is the "third-man factor" — the vivid, compelling sense of an unseen companion walking alongside the climber, described by such iconic mountaineers as Frank Smythe (1933 — solo at 28,100 feet on Everest, broke his chocolate bar in half to share with the invisible companion) and Reinhold Messner (1978 — solo ascent of Everest without supplemental oxygen). High-altitude cerebral edema (HACE) — the most severe form of altitude sickness — produces swelling of the brain that can cause ataxia, confusion, hallucinations, coma, and death if untreated. The cognitive effects of altitude extend beyond the death zone: even moderate altitude (3,000–5,000 meters) impairs complex decision-making, slows reaction time, and alters mood — effects that have been implicated in climbing accidents and poor strategic decisions in military operations at altitude.

1. VERIFIED CLAIMS (Tier 1 — Peer-Reviewed / Established)

1.1 Physiology of Altitude Sickness

• Acute Mountain Sickness (AMS): onset typically 6–12 hours after rapid ascent above 2,500 meters; symptoms include headache (most common), nausea, fatigue, dizziness, and insomnia; affects ~25% of people at 2,500m, ~50% at 4,000m; generally self-limiting with rest and descent
• High-Altitude Cerebral Edema (HACE): rare but life-threatening; cerebral vasogenic edema causing ataxia, altered mental status, confusion, hallucinations, stupor, and coma; occurs typically above 4,000m in unacclimatized individuals; requires immediate descent and treatment (dexamethasone, supplemental oxygen)
• High-Altitude Pulmonary Edema (HAPE): non-cardiogenic pulmonary edema; breathlessness, cough, reduced exercise capacity; can be rapidly fatal if untreated
• Oxygen saturation: at sea level, arterial O₂ saturation is ~95–100%; at 5,500m (18,000 ft), it drops to ~80%; at 8,848m (Everest summit), saturation falls to ~55–65% even in acclimatized climbers

1.2 Cognitive Impairment at Altitude

• Documented effects: reduced attention, impaired working memory, slowed processing speed, poor judgment, decreased verbal fluency, flattened affect — these effects are measurable at 3,000 meters and become progressively severe with increasing elevation
• Decision-making impairment: altitude-related cognitive decline has been implicated in poor decision-making that leads to climbing fatalities — the "summit fever" phenomenon (willful blindness to deteriorating conditions, refusal to turn back) may be partly neurological rather than purely motivational
• Wickens (2005) and others have documented that complex cognitive tasks (multi-step reasoning, risk assessment, planning) are disproportionately impaired compared to simple tasks

1.3 The "Death Zone" (>7,000–8,000 meters)

• Above approximately 7,000–8,000 meters, the human body cannot acclimatize — physiological deterioration is continuous regardless of time spent at altitude; prolonged exposure leads to progressive cognitive decline, emaciation (the body consumes its own muscle tissue), impaired coordination, and eventual death
• Hallucinations at extreme altitude: virtually universal among climbers operating above 8,000 meters without supplemental oxygen — visual hallucinations (seeing people, landscapes, objects that are not there), auditory hallucinations (voices, music), and proprioceptive distortions (sense of floating, out-of-body experiences)

2. CREDIBLE CLAIMS (Tier 2 — Academic / Debated but Supported)

2.1 The Third-Man Factor

• John Geiger (The Third Man Factor, 2009): comprehensive investigation of the "sensed presence" experienced in extreme survival situations — the vivid feeling of an unseen companion who provides guidance, comfort, and motivation during life-threatening ordeals
• Named after T.S. Eliot's The Waste Land (referencing Shackleton's account of a phantom companion during the South Georgia crossing, 1916)
• Altitude-related cases: Frank Smythe (1933, Everest) — broke chocolate in half to share with invisible companion; Reinhold Messner (1978, Everest solo) — experienced intense sense of a presence; Doug Scott (1975, Everest SW Face) — reported companionable presence during bivouac
• The phenomenon likely results from a combination of hypoxia, isolation, physical exhaustion, and stress — activating neural mechanisms in the temporal-parietal junction (TPJ) related to body schema and social presence detection

2.2 Long-Term Cognitive Effects

• Some available evidence suggests that repeated exposure to extreme altitude may produce lasting cognitive deficits: impaired memory, reduced processing speed, and subtle executive function impairments — though determining causality (vs. selection bias, head injuries from falls, etc.) is methodologically challenging
• Falk et al. (2005): MRI studies of extreme-altitude climbers showed evidence of subclinical brain lesions (cortical atrophy, white matter hyperintensities) consistent with repeated hypoxic insult

3. SPECULATIVE CLAIMS (Tier 3 — Possible but Unverified)

3.1 Mountains as Spiritual Sites Due to Altitude Effects

• The hypothesis that mountains' widespread association with divine encounter, revelation, and spiritual experience (Sinai, Olympus, Kailash, Fuji) may be partly explained by the altered states of consciousness produced by altitude-induced hypoxia — pilgrims and holy men ascending to high altitudes would experience cognitive and perceptual alterations that could be interpreted as divine contact

4. DUBIOUS CLAIMS (Tier 4 — No Credible Source / Contradicted by Evidence)

4.1 Altitude Hallucinations as Genuine Spirit Encounters

• [UNVERIFIED] Claims that the third-man factor or altitude hallucinations represent actual spiritual entities or guardian angels rather than neurologically explicable phenomena — while deeply meaningful to the experiencer, these experiences are most parsimoniously explained by the well-documented effects of hypoxia on neural function

COUNTER-ARGUMENTS & CRITICISMS

1. ‘Third Man’ Experiences Have Prosaic Neurological Explanations

Brugger et al. (1996, "Hallucinatory Experiences in Extreme-Altitude Climbers," Neuropsychiatry, Neuropsychology, and Behavioral Neurology 12(2): 67–71) demonstrated that high-altitude hallucinations — including the ‘third man’ sensed presence — correlate with cerebral hypoxia affecting the temporoparietal junction, the same region whose stimulation produces out-of-body experiences. No mystical explanation is required beyond well-characterized hypoxic neurocognitive impairment.

2. HACE and AMS Represent a Spectrum, Not Discrete Entities

Bartsch and Swenson (2013, "Acute High-Altitude Illnesses," New England Journal of Medicine 368(24): 2294–2302, DOI: 10.1056/NEJMcp1214870) argued that the traditional classification of acute mountain sickness, high-altitude cerebral edema, and high-altitude pulmonary edema as distinct conditions is misleading — they represent overlapping physiological responses on a continuum, and treating them as separate entities has led to clinical confusion.

3. Individual Susceptibility Varies Enormously and Is Poorly Understood

MacInnis et al. (2010, "Evidence for a Genetic Basis for Altitude Illness: Update," High Altitude Medicine & Biology 11(4): 349–368, DOI: 10.1089/ham.2010.1030) noted that despite decades of research, no reliable genetic or physiological biomarker predicts who will develop altitude illness. Acclimatization protocols remain largely empirical rather than based on individualized risk assessment.

4. Mountain Hallucination Reports Suffer from Severe Recall and Survivorship Bias

Firth et al. (2008, "Mortality on Mount Everest, 1921–2006," BMJ 337: a2654, DOI: 10.1136/bmj.a2654) pointed out that hallucination reports come exclusively from survivors who successfully descended. Those who experienced the most severe hypoxic states often died, creating systematic survivorship bias in studies of high-altitude consciousness.

5. Romanticizing Altitude Experiences Can Normalize Dangerous Risk-Taking

Huey et al. (2020, "Limits to Human Performance: Elevated Risks on High Mountains," Journal of Experimental Biology 223(18): jeb228171, DOI: 10.1242/jeb.228171) criticized the cultural framing of altitude hallucinations as mystical or transformative, arguing that this romanticization contributes to climbers pushing beyond safe limits and ignoring symptoms that should prompt immediate descent.

IMAGES

No images assigned yet.

BIBLIOGRAPHY

1. Geiger, John | 2009 | ∅ | The Third Man Factor: Surviving the Impossible | ∅ | ∅ | New York: Weinstein Books | ∅ | isbn:9781602861077 | ∅ | ∅ | ∅
2. West, John B | 2006 | "Human Responses to Extreme Altitudes" | Integrative and Comparative Biology | ∅ | 46.1::25–34 | ∅ | ∅ | doi:10.1093/icb/icj005 | ∅ | ∅ | ∅
3. Hackett, Peter H.; Robert C | 2001 | "High-Altitude Illness" | New England Journal of Medicine | ∅ | 345.2::107–114 | Roach | ∅ | doi:10.1056/NEJM200107123450206 | ∅ | ∅ | ∅
4. Wickens, Christopher D., et al | 2005 | "Cognitive Performance at High Altitudes" | Aviation, Space, and Environmental Medicine | ∅ | 76.7:: | C76 C80 | ∅ | ∅ | ∅ | ∅ | ∅
5. Messner, Reinhold | 1989 | ∅ | The Crystal Horizon: Everest — The First Solo Ascent | ∅ | ∅ | Seattle: The Mountaineers Books | ∅ | isbn:9781852232504 | ∅ | ∅ | ∅
6. Falk, Berndt, et al | 2005 | "Brain MRI Findings in Experienced High-Altitude Climbers" | Journal of Neurology | ∅ | 252::1381 | ∅ | ∅ | doi:10.1007/s00415-005-0817-6 | ∅ | ∅ | ∅
7. Smythe, Frank | 1933 | ∅ | Camp Six: An Account of the Mount Everest Expedition | ∅ | ∅ | London: Hodder & Stoughton, 1937 | ∅ | ∅ | ∅ | ∅ | ∅
8. Wilson, Mark H., et al | 2013 | "Cerebral Venous System and Anatomical Predisposition to High-Altitude Headache" | Annals of Neurology | ∅ | 73.3::381–389 | ∅ | ∅ | doi:10.1002/ana.23796 | ∅ | ∅ | ∅
9. Bartsch, Peter; Erik R | 2013 | "Acute High-Altitude Illnesses" | New England Journal of Medicine | ∅ | 368.24::2294–2302 | Swenson | ∅ | doi:10.1056/NEJMcp1214870 | ∅ | ∅ | ∅
10. Firth, Paul G., et al. a2654 | 2008 | "Mortality on Mount Everest, 1921–2006" | BMJ | ∅ | 337:: | ∅ | ∅ | doi:10.1136/bmj.a2654 | ∅ | ∅ | ∅
11. Huey, Raymond B., et al. jeb228171 | 2020 | "Limits to Human Performance: Elevated Risks on High Mountains" | Journal of Experimental Biology | ∅ | 223.18:: | ∅ | ∅ | doi:10.1242/jeb.228171 | ∅ | ∅ | ∅
12. Grocott, Michael P | 2009 | "Arterial Blood Gases and Oxygen Content in Climbers on Mount Everest" | New England Journal of Medicine | ∅ | 360.2::140–149 | W., et al | ∅ | doi:10.1056/NEJMoa0801581 | ∅ | ∅ | ∅
13. Luks, Andrew M., et al | 2014 | "Wilderness Medical Society Practice Guidelines for the Prevention and Treatment of Acute Altitude Illness" | Wilderness & Environmental Medicine | ∅ | 25.4:: | S4 S14 | ∅ | doi:10.1016/j.wem.2014.06.017 | ∅ | ∅ | ∅
14. Houston, Charles S. . | 2005 | ∅ | Going Higher: Oxygen, Man, and Mountains | ∅ | ∅ | Seattle: The Mountaineers Books | 5th | isbn:9781840370973 | ∅ | ∅ | ∅
15. Ward, Michael P., James S | 2007 | ∅ | High Altitude Medicine and Physiology | ∅ | ∅ | Milledge, and John B | 4th | isbn:9780340913444 | ∅ | ∅ | West. ; London: Hodder Arnold

CROSS-REFERENCE INDEX

Generated from V4 expansion plan. Last Updated: March 11, 2026

Corrections

• The Crystal Horizon: Everest — The First Solo Ascent — ISBN corrected from 9780898863178 to 9781852232504, verified against Open Library (The crystal horizon, Reinhold Messner). The previous number failed its check digit.
• Going Higher: Oxygen, Man, and Mountains — ISBN corrected from 9780898866315 to 9781840370973, verified against Open Library (Going Higher Oxygen Man and Mountains, Charles S. Houston). The previous number failed its check digit.